Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney

Kidney International

Volumn 89, Issue 6, 2016, Pages 1281-1292

  Lin, Chi Hua Sarah ^a   Chen, Jun ^a   Zhang, Zhongtao ^a   Johnson, Gail V W ^b   Cooper, Arthur J L ^a   Feola, Julianne ^b   Bank, Alexander ^a   Shein, Jonathan ^a   Ruotsalainen, Heli J ^c   Pihlajaniemi, Taina A ^c   Goligorsky, Michael S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

aging kidney; collagen XVIII; endostatin; fibrosis; tissue transglutaminase

Indexed keywords

6 (GAMMA GLUTAMYL)LYSINE; CREATININE; ENDOSTATIN; FOLIC ACID; MATRIX METALLOPROTEINASE 14; NITROGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SCLEROPROTEIN; UREA; COLLAGEN TYPE 18; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; EXTRACELLULAR SPACE; IMMUNOFLUORESCENCE; IN VITRO STUDY; KIDNEY DISEASE; KIDNEY FIBROSIS; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSGENIC MOUSE; UPREGULATION; UREA NITROGEN BLOOD LEVEL; WILD TYPE MOUSE; ANIMAL; C57BL MOUSE; CELL AGING; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; ENDOTHELIUM CELL; FIBROSIS; GENETICS; KIDNEY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

AGING; ANIMALS; CELL AGING; CELLS, CULTURED; COLLAGEN TYPE XVIII; ENDOSTATINS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; FIBROSIS; FOLIC ACID; GTP-BINDING PROTEINS; KIDNEY; KIDNEY DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TRANSGLUTAMINASES; UP-REGULATION;

EID: 84978140759     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.01.030     Document Type: Article

References (31)

1. 1 O'Reilly, M.S., Boehm, T., Shing, Y., et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 (1997), 277–285.
2. 2 Ferreras, M., Felbor, U., Lenhard, T., et al. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 486 (2000), 247–251.
3. 3 Marneros, A.G., Olsen, B.R., Physiological role of collagen XVIII and endostatin. FASEB J 19 (2005), 716–728.
4. 4 Muragaki, Y., Timmons, S., Griffith, C.M., et al. Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc Natl Acad Sci U S A 92 (1995), 8763–8767.
5. 5 Rehn, M., Pihlajaniemi, T., Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc Natl Acad Sci U S A 91 (1994), 4234–4238.
6. 6 Lin, C.H., Chen, J., Ziman, B., et al. Endostatin and kidney fibrosis in aging: a case for antagonistic pleiotropy?. Am J Physiol Heart Circ Physiol 306 (2014), H1692–H1699.
7. 7 Ruge, T., Carlsson, A.C., Larsson, T.E., et al. Endostatin level is associated with kidney injury in the elderly: findings from two community-based cohorts. Am J Nephrol 40 (2014), 417–424.
8. 8 Faye, C., Inforzato, A., Bignon, M., et al. Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells. Biochem J 427 (2010), 467–475.
9. 9 Gundemir, S., Colak, G., Tucholski, J., et al. Transglutaminase 2: a molecular Swiss army knife. Biochim Biophys Acta 1823 (2012), 406–419.
10. 10 Belkin, A.M., Extracellular TG2: emerging functions and regulation. FEBS J 278 (2011), 4704–4716.
11. 11 Eckert, R.L., Kaartinen, M.T., Nurminskaya, M., et al. Transglutaminase regulation of cell function. Physiol Rev 94 (2014), 383–417.
12. 12 Huang, L., Haylor, J.L., Hau, Z., et al. Transglutaminase inhibition ameliorates experimental diabetic nephropathy. Kidney Int 76 (2009), 383–394.
13. 13 Shweke, N., Boulos, N., Jouanneau, C., et al. Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration. Am J Pathol 173 (2008), 631–642.
14. 14 Johnson, T.S., Fisher, M., Haylor, J.L., et al. Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease. J Am Soc Nephrol 18 (2007), 3078–3088.
15. 15 Olsen, K.C., Sapinoro, R.E., Kottmann, R.M., et al. Transglutaminase 2 and its role in pulmonary fibrosis. Am J Respir Crit Care Med 184 (2011), 699–707.
16. 16 Belkin, A.M., Akimov, S.S., Zaritskaya, L.S., et al. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem 276 (2001), 18415–18422.
17. 17 Nakano, Y., Forsprecher, J., Kaartinen, M.T., Regulation of ATPase activity of transglutaminase 2 by MT1-MMP: implications for mineralization of MC3T3-E1 osteoblast cultures. J Cell Physiol 223 (2010), 260–269.
18. 18 Jones, R.A., Kotsakis, P., Johnson, T.S., et al. Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ 13 (2006), 1442–1453.
19. 19 Wang, Z., Perez, M., Caja, S., et al. A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis. Cell Death Dis, 4, 2013, e808.
20. 20 Baker, M., Robinson, S.D., Lechertier, T., et al. Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc 7 (2012), 89–104.
21. 21 Vasko, R., Xavier, S., Chen, J., et al. Endothelial sirtuin 1 deficiency perpetrates nephrosclerosis through downregulation of matrix metalloproteinase-14: relevance to fibrosis of vascular senescence. J Am Soc Nephrol 25 (2014), 276–291.
22. 22 Elamaa, H., Sormunen, R., Rehn, M., et al. Endostatin overexpression specifically in the lens and skin leads to cataract and ultrastructural alterations in basement membranes. Am J Pathol 166 (2005), 221–229.
23. 23 Narita, M., Nunez, S., Heard, E., et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113 (2003), 703–716.
24. 24 Bedner, E., Li, X., Gorczyca, W., et al. Analysis of apoptosis by laser scanning cytometry. Cytometry 35 (1999), 181–195.
25. 25 Faye, C., Moreau, C., Chautard, E., et al. Molecular interplay between endostatin, integrins, and heparan sulfate. J Biol Chem 284 (2009), 22029–22040.
26. 26 Pierce, B.G., Wiehe, K., Hwang, H., et al. ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers. Bioinformatics 30 (2014), 1771–1773.
27. 27 Kozakov, D., Beglov, D., Bohnuud, T., et al. How good is automated protein docking?. Proteins 81 (2013), 2159–2166.
28. 28 Wang, X., Bonventre, J.V., Parrish, A.R., The aging kidney: increased susceptibility to nephrotoxicity. Int J Mol Sci 15 (2014), 15358–15376.
29. 29 Nanda, N., Iismaa, S.E., Owens, W.A., et al. Targeted inactivation of Gh/tissue transglutaminase II. J Biol Chem 276 (2001), 20673–20678.
30. 30 Colak, G., Johnson, G.V., Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia. Neurobiol Dis 45 (2012), 1042–1050.
31. 31 Cao, J., Sato, H., Takino, T., et al. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 270 (1995), 801–805.